2-(3-Bromo-4,5-dimethoxyphenyl)-5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one

ID: ALA4799426

PubChem CID: 53268365

Max Phase: Preclinical

Molecular Formula: C18H17BrN2O3S

Molecular Weight: 421.32

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(-c2nc3sc4c(c3c(=O)[nH]2)CCCC4)cc(Br)c1OC

Standard InChI:  InChI=1S/C18H17BrN2O3S/c1-23-12-8-9(7-11(19)15(12)24-2)16-20-17(22)14-10-5-3-4-6-13(10)25-18(14)21-16/h7-8H,3-6H2,1-2H3,(H,20,21,22)

Standard InChI Key:  NQGJMKNUTZFWGK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   21.4822   -2.5878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4822   -3.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1916   -3.8177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1916   -2.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9010   -2.5878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9055   -3.4056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6848   -3.6569    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.6776   -2.3322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1546   -2.9904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9593   -2.9049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2932   -2.1620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8121   -1.5038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0012   -1.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1077   -2.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5879   -2.7402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4040   -2.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7410   -1.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2516   -1.2407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4373   -1.3293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5188   -0.9246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.5577   -1.8167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0391   -2.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8832   -3.3168    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5496   -4.0628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5798   -0.4923    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 11 14  1  0
 13 20  2  0
 17 21  1  0
 21 22  1  0
 16 23  1  0
 23 24  1  0
 18 25  1  0
M  END

Associated Targets(Human)

KB-V1 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
518A2 (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.32Molecular Weight (Monoisotopic): 420.0143AlogP: 4.31#Rotatable Bonds: 3
Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.03CX Basic pKa: 0.71CX LogP: 4.61CX LogD: 4.53
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.68Np Likeness Score: -1.27

References

1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R.  (2020)  Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones.,  189  [PMID:31958738] [10.1016/j.ejmech.2020.112060]

Source